China Resources Medical Holdings Company akcijos akcijų analizė | Akcijų kaina | Naujienos | 1515.HK | KYG2133W1087 | A2DHMW

Data	China Resources Medical Holdings Company Akcijų kaina
2024-09-24	3,20 undefined
2024-09-23	3,08 undefined
2024-09-20	3,12 undefined
2024-09-19	3,14 undefined
2024-09-17	3,09 undefined
2024-09-16	3,09 undefined
2024-09-13	3,16 undefined
2024-09-12	3,18 undefined
2024-09-11	3,06 undefined
2024-09-10	3,06 undefined
2024-09-09	3,07 undefined
2024-09-05	3,11 undefined
2024-09-04	3,17 undefined
2024-09-03	3,17 undefined
2024-09-02	3,18 undefined
2024-08-30	3,23 undefined
2024-08-29	3,26 undefined
2024-08-28	3,16 undefined
2024-08-27	3,13 undefined

Data	China Resources Medical Holdings Company Pajamos	China Resources Medical Holdings Company EBIT	China Resources Medical Holdings Company Pelnas
2026e	12,04 mlrd. undefined	1,27 mlrd. undefined	841,00 mln. undefined
2025e	11,42 mlrd. undefined	1,18 mlrd. undefined	768,73 mln. undefined
2024e	10,89 mlrd. undefined	1,05 mlrd. undefined	639,52 mln. undefined
2023	10,11 mlrd. undefined	1,02 mlrd. undefined	257,68 mln. undefined
2022	7,90 mlrd. undefined	593,70 mln. undefined	265,86 mln. undefined
2021	4,45 mlrd. undefined	354,33 mln. undefined	417,92 mln. undefined
2020	2,75 mlrd. undefined	300,37 mln. undefined	310,13 mln. undefined
2019	2,12 mlrd. undefined	516,91 mln. undefined	390,87 mln. undefined
2018	2,06 mlrd. undefined	537,35 mln. undefined	430,90 mln. undefined
2017	1,88 mlrd. undefined	460,93 mln. undefined	421,03 mln. undefined
2016	1,53 mlrd. undefined	289,12 mln. undefined	−1,51 mlrd. undefined
2015	1,37 mlrd. undefined	230,19 mln. undefined	167,05 mln. undefined
2014	1,21 mlrd. undefined	256,29 mln. undefined	230,05 mln. undefined
2013	887,40 mln. undefined	199,10 mln. undefined	90,00 mln. undefined
2012	758,00 mln. undefined	164,60 mln. undefined	101,10 mln. undefined
2011	509,50 mln. undefined	90,90 mln. undefined	48,10 mln. undefined
2010	394,10 mln. undefined	67,50 mln. undefined	42,80 mln. undefined

	Pajamos	EBIT	Pelnas
2010	394,10 mln. CNY	67,50 mln. CNY	42,80 mln. CNY
2011	509,50 mln. CNY	90,90 mln. CNY	48,10 mln. CNY
2012	758,00 mln. CNY	164,60 mln. CNY	101,10 mln. CNY
2013	887,40 mln. CNY	199,10 mln. CNY	90,00 mln. CNY
2014	1,21 mlrd. CNY	256,29 mln. CNY	230,05 mln. CNY
2015	1,37 mlrd. CNY	230,19 mln. CNY	167,05 mln. CNY
2016	1,53 mlrd. CNY	289,12 mln. CNY	−1,51 mlrd. CNY
2017	1,88 mlrd. CNY	460,93 mln. CNY	421,03 mln. CNY
2018	2,06 mlrd. CNY	537,35 mln. CNY	430,90 mln. CNY
2019	2,12 mlrd. CNY	516,91 mln. CNY	390,87 mln. CNY
2020	2,75 mlrd. CNY	300,37 mln. CNY	310,13 mln. CNY
2021	4,45 mlrd. CNY	354,33 mln. CNY	417,92 mln. CNY
2022	7,90 mlrd. CNY	593,70 mln. CNY	265,86 mln. CNY
2023	10,11 mlrd. CNY	1,02 mlrd. CNY	257,68 mln. CNY
2024e	10,89 mlrd. CNY	1,05 mlrd. CNY	639,52 mln. CNY
2025e	11,42 mlrd. CNY	1,18 mlrd. CNY	768,73 mln. CNY
2026e	12,04 mlrd. CNY	1,27 mlrd. CNY	841,00 mln. CNY

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,39	0,51	0,76	0,89	1,21	1,37	1,53	1,88	2,06	2,12	2,75	4,45	7,90	10,11	10,89	11,42	12,04
-	29,19	48,92	17,02	35,96	13,76	11,66	22,52	9,70	2,72	30,02	61,71	77,67	27,92	7,75	4,86	5,43
23,35	23,97	24,27	23,90	24,63	23,98	26,50	35,59	36,72	36,03	23,13	20,98	16,52	18,85	-	-	-
0,09	0,12	0,18	0,21	0,30	0,33	0,41	0,67	0,76	0,76	0,64	0,93	1,31	1,91	0	0	0
0,07	0,09	0,16	0,20	0,26	0,23	0,29	0,46	0,54	0,52	0,30	0,35	0,59	1,02	1,05	1,18	1,27
17,01	17,68	21,64	22,44	21,23	16,76	18,86	24,51	26,08	24,40	10,91	7,96	7,51	10,11	9,63	10,37	10,56
42,00	48,00	101,00	90,00	230,00	167,00	−1 506,00	421,00	430,00	390,00	310,00	417,00	265,00	257,00	639,00	768,00	841,00
-	14,29	110,42	−10,89	155,56	−27,39	−1 001,80	−127,95	2,14	−9,30	−20,51	34,52	−36,45	−3,02	148,64	20,19	9,51
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,60	0,60	0,60	0,58	0,83	0,82	0,90	1,28	1,27	1,25	1,26	1,26	1,26	1,26	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

0,32	0,35	0,17	1,28	1,07	1,01	1,19	1,59	1,90	2,28	2,97	2,64	3,42
0,02	0,02	0,08	0,08	0,09	0,14	0,26	0,35	0,51	0,63	0,64	0,79	1,51
0,04	0,08	0,06	0,07	0,08	0,07	0,13	0,10	0,02	0,21	0,29	0,17	1,06
22,30	23,20	35,10	31,10	33,83	42,32	50,24	38,60	77,89	62,12	142,04	185,08	367,48
3,10	8,90	10,10	10,30	15,69	27,23	25,24	27,46	29,46	19,59	102,89	141,26	399,51
0,41	0,49	0,37	1,47	1,29	1,29	1,65	2,11	2,53	3,20	4,15	3,92	6,77
0,09	0,11	0,12	0,12	0,14	0,15	0,26	0,26	0,26	0,34	1,05	2,12	5,42
0	0	0	0	0	0,15	0,68	0,67	0,67	0,63	0,75	1,93	1,57
22,30	36,10	48,50	51,20	68,99	109,42	113,00	160,88	161,66	136,04	128,41	58,90	60,25
0,11	0,16	0,32	0,32	0,36	0,40	2,13	2,11	2,10	2,04	1,35	0,08	0,07
0	0	0	0	0	0	1,46	1,46	1,46	1,46	1,47	2,28	3,74
31,20	346,10	162,50	158,90	151,79	147,40	143,72	140,35	136,97	76,27	76,46	86,45	191,86
0,25	0,64	0,66	0,65	0,72	0,96	4,79	4,80	4,79	4,68	4,82	6,54	11,05
0,66	1,13	1,02	2,12	2,01	2,26	6,45	6,91	7,32	7,87	8,96	10,47	17,82

130,60	165,60	140,60	0,20	0,17	0,17	0,27	0,27	0,27	0,27	0,27	0,27	0,27
0	0	0	1,54	1,50	1,38	6,37	6,30	6,18	5,99	5,88	5,79	0
0,15	0,43	0,34	0,07	0,30	0,50	−1,01	−0,60	−0,19	0,21	0,53	0,96	9,51
0	0	0	0	0	6,76	16,98	−0,54	−15,70	−17,03	−21,27	−14,66	0
0	0	0	0	0	0	−16,27	−16,27	0	0	0	0	0
0,28	0,59	0,49	1,62	1,80	1,89	5,35	5,68	5,97	6,19	6,39	6,73	9,51
0,08	0,09	0,12	0,12	0,17	0,21	0,24	0,26	0,22	0,24	0,56	0,83	1,73
10,30	13,10	18,80	17,80	17,06	23,15	59,18	92,17	106,24	106,39	279,03	435,53	0
0,06	0,03	0,05	0,06	0,08	0,16	0,45	0,46	0,46	0,45	0,66	0,49	2,04
0	0	0	0	0	0	0	0,17	0,49	0,58	0,68	1,67	0
0	0,20	0,01	0,20	0	0	0	0	0	0,01	0,02	0,02	1,35
0,14	0,33	0,20	0,40	0,27	0,39	0,75	0,98	1,28	1,38	2,21	3,44	5,12
0,20	0	0,23	0	0	0	0	0	0	0,01	0,05	0,04	1,05
0	0	0	0	0	0	318,88	317,63	316,37	317,83	317,62	95,25	71,32
12,60	10,50	8,60	5,30	3,23	2,92	19,58	18,39	16,02	18,12	51,16	41,92	915,48
0,21	0,01	0,24	0,01	0,00	0,00	0,34	0,34	0,33	0,35	0,42	0,18	2,04
0,36	0,34	0,44	0,41	0,28	0,39	1,09	1,31	1,61	1,73	2,62	3,62	7,16
0,64	0,93	0,93	2,03	2,08	2,28	6,44	6,99	7,58	7,92	9,01	10,35	16,67

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
65,00	78,00	147,00	143,00	316,00	247,00	−1 452,00	559,00	588,00	541,00	418,00	270,00	242,00
17,00	17,00	32,00	33,00	35,00	41,00	47,00	63,00	69,00	63,00	113,00	182,00	332,00
0	0	0	0	0	0	0	0	0	0	0	0	0
−14,00	−48,00	−33,00	−41,00	−34,00	−86,00	−107,00	−76,00	−276,00	−226,00	211,00	40,00	−111,00
0,00	0,01	0,02	0,04	−0,04	0,03	1,74	−0,09	−0,05	−0,01	−0,10	0,22	0,16
0	18,00	23,00	32,00	0	0	0	1,00	6,00	16,00	14,00	19,00	46,00
11,00	20,00	27,00	41,00	59,00	80,00	71,00	60,00	162,00	163,00	98,00	135,00	135,00
70,00	62,00	166,00	169,00	274,00	231,00	223,00	459,00	334,00	366,00	643,00	710,00	626,00
−17,00	−34,00	−28,00	−21,00	−36,00	−32,00	−42,00	−34,00	−57,00	−36,00	−209,00	−227,00	−252,00
−328,00	−36,00	−102,00	−841,00	360,00	29,00	120,00	−545,00	355,00	157,00	60,00	−1 936,00	57,00
−310,00	−1,00	−74,00	−820,00	397,00	61,00	162,00	−510,00	413,00	193,00	269,00	−1 708,00	310,00
0	0	0	0	0	0	0	0	0	0	0	0	0
200,00	0	32,00	−41,00	0	0	0	180,00	303,00	73,00	131,00	966,00	143,00
0	0	−0,20	1,39	−0,18	−0,02	0	−0,10	−0,21	0	0	0	0
298,00	230,00	−282,00	971,00	−421,00	−48,00	−98,00	−104,00	−44,00	−40,00	−7,00	845,00	−33,00
98,00	230,00	−114,00	−379,00	−1,00	7,00	−15,00	−112,00	−15,00	17,00	−23,00	−29,00	−47,00
0	0	0	0	−44,00	−32,00	−83,00	−69,00	−118,00	−131,00	−115,00	−91,00	−129,00
40,00	256,00	−217,00	288,00	209,00	210,00	247,00	−192,00	647,00	482,00	695,00	−377,00	653,00
52,90	28,10	138,30	148,40	237,96	199,53	181,34	425,04	276,54	329,69	434,14	483,17	373,72
0	0	0	0	0	0	0	0	0	0	0	0	0

China Resources Medical Holdings Company Bruto marža	China Resources Medical Holdings Company Pelnas-martža	China Resources Medical Holdings Company EBIT marža	China Resources Medical Holdings Company Pelnas-martža
2026e	18,86 %	10,56 %	6,99 %
2025e	18,86 %	10,37 %	6,73 %
2024e	18,86 %	9,63 %	5,87 %
2023	18,86 %	10,12 %	2,55 %
2022	16,53 %	7,51 %	3,36 %
2021	20,99 %	7,97 %	9,40 %
2020	23,14 %	10,92 %	11,27 %
2019	36,04 %	24,44 %	18,48 %
2018	36,74 %	26,09 %	20,92 %
2017	35,59 %	24,55 %	22,42 %
2016	26,53 %	18,86 %	−98,31 %
2015	24,02 %	16,77 %	12,17 %
2014	24,68 %	21,25 %	19,07 %
2013	23,97 %	22,44 %	10,14 %
2012	24,38 %	21,72 %	13,34 %
2011	24,08 %	17,84 %	9,44 %
2010	23,57 %	17,13 %	10,86 %

	Bruto marža	EBIT marža	Pelnas-martža
2010	23,57 %	17,13 %	10,86 %
2011	24,08 %	17,84 %	9,44 %
2012	24,38 %	21,72 %	13,34 %
2013	23,97 %	22,44 %	10,14 %
2014	24,68 %	21,25 %	19,07 %
2015	24,02 %	16,77 %	12,17 %
2016	26,53 %	18,86 %	−98,31 %
2017	35,59 %	24,55 %	22,42 %
2018	36,74 %	26,09 %	20,92 %
2019	36,04 %	24,44 %	18,48 %
2020	23,14 %	10,92 %	11,27 %
2021	20,99 %	7,97 %	9,40 %
2022	16,53 %	7,51 %	3,36 %
2023	18,86 %	10,12 %	2,55 %
2024e	18,86 %	9,63 %	5,87 %
2025e	18,86 %	10,37 %	6,73 %
2026e	18,86 %	10,56 %	6,99 %

Data	China Resources Medical Holdings Company Pardavimai vienai akcijai	China Resources Medical Holdings Company EBIT vienai akcijai	China Resources Medical Holdings Company Pelnas vienai akcijai
2026e	9,34 undefined	0 undefined	0,65 undefined
2025e	8,86 undefined	0 undefined	0,60 undefined
2024e	8,45 undefined	0 undefined	0,50 undefined
2023	7,99 undefined	0,81 undefined	0,20 undefined
2022	6,26 undefined	0,47 undefined	0,21 undefined
2021	3,52 undefined	0,28 undefined	0,33 undefined
2020	2,18 undefined	0,24 undefined	0,25 undefined
2019	1,69 undefined	0,41 undefined	0,31 undefined
2018	1,62 undefined	0,42 undefined	0,34 undefined
2017	1,47 undefined	0,36 undefined	0,33 undefined
2016	1,70 undefined	0,32 undefined	−1,67 undefined
2015	1,67 undefined	0,28 undefined	0,20 undefined
2014	1,45 undefined	0,31 undefined	0,28 undefined
2013	1,54 undefined	0,35 undefined	0,16 undefined
2012	1,26 undefined	0,27 undefined	0,17 undefined
2011	0,85 undefined	0,15 undefined	0,08 undefined
2010	0,65 undefined	0,11 undefined	0,07 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2010	0,65 CNY	0,11 CNY	0,07 CNY
2011	0,85 CNY	0,15 CNY	0,08 CNY
2012	1,26 CNY	0,27 CNY	0,17 CNY
2013	1,54 CNY	0,35 CNY	0,16 CNY
2014	1,45 CNY	0,31 CNY	0,28 CNY
2015	1,67 CNY	0,28 CNY	0,20 CNY
2016	1,70 CNY	0,32 CNY	−1,67 CNY
2017	1,47 CNY	0,36 CNY	0,33 CNY
2018	1,62 CNY	0,42 CNY	0,34 CNY
2019	1,69 CNY	0,41 CNY	0,31 CNY
2020	2,18 CNY	0,24 CNY	0,25 CNY
2021	3,52 CNY	0,28 CNY	0,33 CNY
2022	6,26 CNY	0,47 CNY	0,21 CNY
2023	7,99 CNY	0,81 CNY	0,20 CNY
2024e	8,45 CNY	0 CNY	0,50 CNY
2025e	8,86 CNY	0 CNY	0,60 CNY
2026e	9,34 CNY	0 CNY	0,65 CNY

	Akcijų skaičius
2010	602,70 mln. Aktien
2011	602,70 mln. Aktien
2012	602,70 mln. Aktien
2013	575,80 mln. Aktien
2014	830,87 mln. Aktien
2015	819,35 mln. Aktien
2016	901,56 mln. Aktien
2017	1,28 mlrd. Aktien
2018	1,27 mlrd. Aktien
2019	1,25 mlrd. Aktien
2020	1,26 mlrd. Aktien
2021	1,26 mlrd. Aktien
2022	1,26 mlrd. Aktien
2023	1,26 mlrd. Aktien
2024e	1,26 mlrd. Aktien
2025e	1,26 mlrd. Aktien
2026e	1,26 mlrd. Aktien

Data	China Resources Medical Holdings Company Dividendas
2026e	0,04 undefined
2025e	0,04 undefined
2024e	0,04 undefined
2023	0,04 undefined
2022	0,12 undefined
2021	0,09 undefined
2020	0,10 undefined
2019	0,12 undefined
2018	0,11 undefined
2017	0,06 undefined
2016	0,12 undefined
2015	0,05 undefined
2014	0,07 undefined

	Dividendas	Dividenda (įvertinimas)
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0,07 CNY	0 CNY
2015	0,05 CNY	0 CNY
2016	0,12 CNY	0 CNY
2017	0,06 CNY	0 CNY
2018	0,11 CNY	0 CNY
2019	0,12 CNY	0 CNY
2020	0,10 CNY	0 CNY
2021	0,09 CNY	0 CNY
2022	0,12 CNY	0 CNY
2023	0,04 CNY	0 CNY
2024e	0 CNY	0,04 CNY
2025e	0 CNY	0,04 CNY
2026e	0 CNY	0,04 CNY

Data	China Resources Medical Holdings Company Išmokėjimo santykis
2026e	43,27 %
2025e	46,69 %
2024e	41,69 %
2023	41,43 %
2022	56,96 %
2021	26,67 %
2020	40,66 %
2019	38,52 %
2018	32,36 %
2017	19,16 %
2016	−7,18 %
2015	24,52 %
2014	24,20 %
2013	41,43 %
2012	41,43 %
2011	41,43 %
2010	41,43 %

	Išmokėjimo santykis
2010	41,43 %
2011	41,43 %
2012	41,43 %
2013	41,43 %
2014	24,20 %
2015	24,52 %
2016	−7,18 %
2017	19,16 %
2018	32,36 %
2019	38,52 %
2020	40,66 %
2021	26,67 %
2022	56,96 %
2023	41,43 %
2024e	41,69 %
2025e	46,69 %
2026e	43,27 %

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2018-12-31	0,16	0,18 (10,29 %)	2018 Q4
2018-06-30	0,15	0,16 (4,58 %)	2018 Q2
2017-06-30	0,12	0,18 (47,88 %)	2017 Q2
2016-06-30	0,17	0,16 (−7,73 %)	2016 Q2
2015-12-31	0,17	0,17 (−4,84 %)	2015 Q4

%	Pavadinimas	Akcijos	Pokytis	Data
5,02656 %	First Sentier Investors (Hong Kong) Limited	64 757 166	−467 000	2024-04-12
36,81744 %	China Resources Co Ltd	474 319 516	0	2022-12-31
3,42030 %	British Columbia Investment Management Corp.	44 063 720	5 307 078	2023-03-31
2,79258 %	Norges Bank Investment Management (NBIM)	35 976 873	10 294 190	2023-12-31
1,47532 %	The Vanguard Group, Inc.	19 006 588	0	2024-03-31
1,29939 %	Dimensional Fund Advisors, L.P.	16 740 000	200 000	2024-02-29
1,10572 %	BlackRock Institutional Trust Company, N.A.	14 245 000	−22 000	2024-03-31
1,04929 %	Bosera Asset Management Co., Ltd.	13 518 000	3 299 000	2023-12-31
0,94663 %	China Merchants Fund Management Co. Ltd.	12 195 500	8 981 500	2023-06-30
0,83514 %	FIL Investment Management (Hong Kong) Limited	10 759 163	10 759 163	2024-02-29
0,37567 %	APG Asset Management N.V.	4 839 763	3 685 428	2023-09-30
0,31192 %	Huisheng Fund Management Co., Ltd.	4 018 500	4 018 500	2023-06-30
0,28914 %	BlackRock Advisors (UK) Limited	3 725 000	−59 000	2024-03-31
0,27482 %	Truvalue Asset Management Co., Ltd.	3 540 500	−56 500	2023-12-31
0,25848 %	Tianhong Asset Management Co., Ltd.	3 330 000	−159 000	2023-12-31
0,25417 %	Taikang Asset Management Co., Ltd.	3 274 500	−170 000	2023-12-31
0,25099 %	California State Teachers Retirement System	3 233 500	58 500	2023-06-30
0,22988 %	American Century Investment Management, Inc.	2 961 500	109 000	2024-03-31
0,17981 %	Wellington Management Company, LLP	2 316 433	−1 437 500	2023-09-30
0,17127 %	State Street Global Advisors (US)	2 206 500	−37 500	2024-03-31
0,17077 %	BOCOM International Asset Management Limited	2 200 000	2 200 000	2023-06-30
0,14539 %	Dimensional Fund Advisors, Ltd.	1 873 000	228 500	2024-02-29
0,13776 %	Cheng (Libing)	1 774 746	0	2023-02-27
0,13324 %	BlackRock Fund Management Co., Ltd.	1 716 500	1 716 500	2023-06-30
0,12013 %	E Fund Management Co. Ltd.	1 547 695	1 515 152	2023-12-31
0,09928 %	GF Fund Management Co., Ltd.	1 279 000	1 279 000	2023-06-30
0,08034 %	Penghua Fund Management Co., Ltd.	1 035 000	965 000	2023-12-31
0,07762 %	Wu (Ting Yuk)	1 000 000	0	2022-12-31
0,07058 %	Bessemer Trust Company, N.A. (US)	909 312	0	2024-01-31
0,06659 %	Numeric Investors LLC	857 910	−17 182	2024-02-29
0,05951 %	Mackenzie Financial Corporation	766 699	−2 049 575	2023-12-31
0,05810 %	Mellon Investments Corporation	748 500	−46 500	2024-03-31
0,05616 %	Nuveen LLC	723 500	0	2024-03-31
0,04937 %	Asset Management One Co., Ltd.	636 000	611 500	2023-11-30
0,04657 %	Florida State Board of Administration	600 000	600 000	2022-09-30
0,04312 %	Avantis Investors	555 500	13 500	2024-03-31
0,03679 %	Everbright PGIM Fund Management Co., Ltd.	474 000	474 000	2023-06-30
0,03609 %	Geode Capital Management, L.L.C.	465 000	0	2024-02-29
0,03105 %	Song (Qing)	400 000	0	2022-12-31
0,02810 %	JPMorgan Asset Management (China) Company Limited.	362 000	362 000	2023-06-30
0,02775 %	Yinhua Fund Management Co., Ltd.	357 500	357 500	2023-12-31
0,02406 %	Margetts Fund Management Limited	310 000	310 000	2023-12-31
0,02333 %	Segall Bryant & Hamill, LLC	300 500	0	2024-02-29
0,02329 %	Ren (Yuan)	300 000	0	2023-06-13
0,02088 %	Allianz Global Investors GmbH	268 951	32 500	2024-01-31
0,01824 %	State Street Global Advisors Ireland Limited	235 000	12 000	2024-03-31
0,01801 %	Western Leadbank Fund Management Co., Ltd.	232 000	112 000	2023-12-31
0,01739 %	DFA Australia Ltd.	224 004	12 004	2023-12-31
0,01265 %	Parametric Portfolio Associates LLC	163 000	0	2024-01-31
0,01063 %	Essence Fund Management Co., Ltd.	137 000	93 500	2023-12-31
0,00944 %	ASPOMA Asset Management GmbH	121 600	0	2024-02-29
0,00939 %	LSV Asset Management	121 000	0	2023-12-31
0,00910 %	JPMorgan Asset Management U.K. Limited	117 256	−23 000	2023-12-31
0,00819 %	Huatai-PineBridge Fund Management Co., Ltd.	105 500	105 500	2023-06-30
0,00776 %	Fullgoal Fund Management Co., Ltd.	100 000	90 500	2023-12-31
0,00761 %	Lazard Asset Management, L.L.C.	98 000	0	2024-01-31
0,00734 %	RAM Active Investments S.A.	94 500	94 500	2023-12-31
0,00718 %	FIL Investment Management (Australia) Limited	92 500	92 500	2024-02-29
0,00554 %	HSBC Global Asset Management (UK) Limited	71 400	42 000	2024-01-31
0,00547 %	Allianz Global Investors U.S. LLC_NLE	70 500	0	2023-10-31
0,00512 %	Ge (Lu)	66 000	66 000	2023-09-14
0,00493 %	State Street Global Advisors (UK) Ltd.	63 500	0	2024-02-29
0,00481 %	INVESCO Great Wall Fund Management Co. Ltd.	62 000	43 500	2023-12-31
0,00431 %	Vanguard Global Advisers LLC	55 500	0	2024-02-29
0,00321 %	Vanguard Investments Australia Ltd.	41 324	100	2024-02-29
0,00268 %	Bank of Beijing Scotiabank Asset Management Co., Ltd.	34 500	34 500	2023-06-30
0,00260 %	Lundgreen's Capital ApS	33 500	−60 000	2024-02-29
0,00147 %	Natixis Investment Managers SA	19 000	0	2023-08-31
0,00105 %	Irish Life Investment Managers Ltd.	13 500	0	2024-02-29
0,00081 %	CI Global Asset Management	10 480	−699	2024-03-31
0,00035 %	Fidelity International	4 489	4 489	2024-02-29
0,00019 %	Krane Funds Advisors, LLC	2 500	0	2023-09-30
0,00019 %	BlackRock Investment Management (Australia) Ltd.	2 500	0	2023-12-31
0,00005 %	BMO Asset Management Inc.	660	0	2023-11-30
0 %	Finlabo SIM S.p. A.	0	−50 000	2024-02-29
0 %	Dimensional Fund Advisors Canada ULC	0	−20 500	2022-07-31
0 %	Prudential Capital Group	0	−21 000	2022-10-31
0 %	Ping An Fund Management Company Limited	0	−53 000	2023-06-30
0 %	Union Investment Luxembourg S.A.	0	−431 000	2023-09-30
0 %	CITIC Prudential Fund Management Co., Ltd.	0	−933 322	2023-12-31
0 %	HuaAn Fund Management Co., Ltd.	0	−1 203 500	2023-12-31
0 %	China Asset Management Co., Ltd.	0	−245 500	2022-12-31
0 %	SEI Investments Management Corporation	0	−297 898	2023-06-30
0 %	First Trust Advisors L.P.	0	−2 974 867	2023-10-31
0 %	Allianz Global Investors Asia Pacific Limited	0	−134 500	2023-05-31
0 %	Handelsbanken Kapitalförvaltning AB	0	−200 000	2022-12-31
0 %	PGGM Vermogensbeheer B.V.	0	−12 791 942	2023-07-31
0 %	Wilmington Trust Investment Management LLC	0	−21 000	2023-09-30
0 %	BlackRock Financial Management, Inc.	0	−22 000	2022-12-31
0 %	Loomis, Sayles & Company, L.P.	0	−29 000	2023-12-31
0 %	Victory Capital Management Inc.	0	−385 000	2022-12-31
0 %	Northern Trust Investments, Inc.	0	−24 500	2023-12-31
0 %	PineStone Asset Management Inc.	0	−93 770	2023-06-30

Pavadinimas	Santykis	Dviejų savaičių koreliacija	Vieno mėnesio koreliacija	Trymėnesio koreliacija	Šešių mėnesių koreliacija	Vienmečio koreliacija	Dviejų metų koreliacija
UMP Healthcare Holdings	TiekėjasKlientas	0,29	0,21	0,32	0,44	0,81	0,04
Mitsubishi UFJ Financial Group	TiekėjasKlientas	-0,31	-0,10	0,30	-0,48	-0,60	-0,14

What values and corporate philosophy does China Resources Medical Holdings Company represent?

China Resources Medical Holdings Company Ltd represents values and a corporate philosophy centered on the provision of high-quality medical services and the promotion of public health in China. The company is committed to delivering accessible, efficient, and patient-centric healthcare, aiming to enhance the overall well-being of individuals and communities. China Resources Medical Holdings Company Ltd prioritizes innovation, leveraging cutting-edge technology and medical advancements to elevate the standards of healthcare delivery. With a focus on professionalism, integrity, and transparency, the company is dedicated to fostering a culture of continuous improvement in the medical field.

In which countries and regions is China Resources Medical Holdings Company primarily present?

China Resources Medical Holdings Company Ltd (CRMH) primarily operates in the Asia-Pacific region, with a focused presence in China. As a leading integrated medical service provider, CRMH has established a strong foothold in various provinces and municipalities across Mainland China. Through its extensive network, CRMH delivers comprehensive healthcare services, including medical consultations, surgeries, diagnostics, and pharmaceutical products. With a commitment to enhancing the accessibility and quality of healthcare, CRMH continually expands its presence to better serve the growing healthcare needs of the Chinese population.

What significant milestones has the company China Resources Medical Holdings Company achieved?

China Resources Medical Holdings Company Ltd has achieved several significant milestones in recent years. The company has successfully expanded its presence in the healthcare sector, becoming one of the leading integrated medical service providers in China. China Resources Medical Holdings Company Ltd has also achieved remarkable growth in terms of revenue and market share. The company has made strategic acquisitions and partnerships to enhance its capabilities and broaden its service offerings. Furthermore, China Resources Medical Holdings Company Ltd has been recognized for its commitment to quality patient care, innovative technologies, and efficient healthcare delivery. Overall, the company has shown outstanding progress and stands as a prominent player in the Chinese medical industry.

What is the history and background of the company China Resources Medical Holdings Company?

China Resources Medical Holdings Company Ltd, also known as CR Medical, is a reputable healthcare service provider in China. Established in 2005, it is a subsidiary of China Resources Corporation, a Fortune Global 500 company. With a strong focus on both medical services and pharmaceutical products, CR Medical has grown into a leading integrated healthcare group. The company operates a vast network of hospitals, clinics, and pharmacies across the country, offering a wide range of medical specialties and healthcare services to patients. Committed to promoting accessible and high-quality healthcare, China Resources Medical Holdings Company Ltd continues to expand its reach and enhance the well-being of communities it serves.

Who are the main competitors of China Resources Medical Holdings Company in the market?

Some of the main competitors of China Resources Medical Holdings Company Ltd in the market include Beijing Gehua CATV Network Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is China Resources Medical Holdings Company primarily active?

China Resources Medical Holdings Company Ltd is primarily active in the healthcare industry.

What is the business model of China Resources Medical Holdings Company?

The business model of China Resources Medical Holdings Company Ltd focuses on providing comprehensive healthcare services in China. The company aims to offer a wide range of medical services, including hospital operations, the distribution of pharmaceutical and healthcare products, medical device manufacturing and sales, as well as healthcare management. China Resources Medical Holdings Company Ltd aims to establish a complete healthcare chain by integrating medical resources and promoting the development of high-quality healthcare services across the country. With its diverse healthcare offerings, the company strives to improve the overall well-being and medical care accessibility for individuals in China.

Koks yra China Resources Medical Holdings Company 2024 KGV?

China Resources Medical Holdings Company KGV yra 6,32.

Koks China Resources Medical Holdings Company 2024 KUV?

China Resources Medical Holdings Company KUV yra 0,37.

Koks yra China Resources Medical Holdings Company AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis China Resources Medical Holdings Company yra 7/10.

Koks yra China Resources Medical Holdings Company 2024 pajamų dydis?

tikėtina China Resources Medical Holdings Company pardavimai yra 10,89 mlrd. CNY.

Kokia yra China Resources Medical Holdings Company 2024 pelnas?

tikėtina China Resources Medical Holdings Company pelnas yra 639,52 mln. CNY.

Ką daro China Resources Medical Holdings Company?

China Resources Medical Holdings Company Ltd is one of the leading companies in the healthcare sector in China. The company offers a wide range of medical services and products and is divided into several divisions. The divisions of China Resources Medical Holdings include hospitals, medical facilities, diagnostic centers, as well as the sale of pharmaceuticals and medical products. The company owns and operates several hospitals and medical facilities nationwide. These provide comprehensive care for various health issues and have state-of-the-art medical equipment and technologies. In addition, the company also offers specialized services in areas such as ophthalmology, plastic surgery, and geriatrics. Furthermore, China Resources Medical Holdings operates diagnostic centers that offer a complete range of diagnostic services for patients. These include ultrasound, endoscopy, magnetic resonance imaging, and computed tomography. The company is also involved in the sale of pharmaceuticals and medical products. It distributes a wide range of products, including generic drugs, over-the-counter products, and medical devices for use in hospitals and medical facilities. Additionally, they are engaged in pharmaceutical research and development and have a strong product pipeline in various therapy areas. The company also works closely with other companies to advance research and development of new therapies. Overall, the business model of China Resources Medical Holdings is focused on meeting the needs of patients by offering a complete range of products and services to improve their health and well-being. The company places special emphasis on the quality, safety, and effectiveness of its products and services and has an excellent reputation in the industry. Given the expanding healthcare sector in China, China Resources Medical Holdings is well positioned to continue growing and increasing its market share. The company will also continue to invest in research and development and introduce new products and services to meet consumer demands.

Kokia yra China Resources Medical Holdings Company dividendė?

China Resources Medical Holdings Company moka dividendą 0,12 CNY, kuris yra paskirstytas per išmokas per metus.

Kiek kartų China Resources Medical Holdings Company moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota China Resources Medical Holdings Company arba įmonė dividendų nemoka.

Kas yra China Resources Medical Holdings Company ISIN?

China Resources Medical Holdings Company ISIN yra KYG2133W1087.

Kas yra China Resources Medical Holdings Company WKN?

China Resources Medical Holdings Company WKN yra A2DHMW.

Kas yra China Resources Medical Holdings Company Tickeris?

China Resources Medical Holdings Company akcijų simbolis yra 1515.HK.

Kiek dividendų moka China Resources Medical Holdings Company?

Per paskutinius 12 mėnesių China Resources Medical Holdings Company išmokėjo dividendą, kurios dydis siekė 0,04 CNY . Tai atitinka maždaug 1,16 % dividendų grąžą. Artimiausiems 12 mėnesiams China Resources Medical Holdings Company tikėtina išmokės dividendus, kurie sudarys 0,04 CNY.

Kokia yra China Resources Medical Holdings Company dividendų grąža?

China Resources Medical Holdings Company šiuo metu yra 1,16 % dydžio dividendų grąža.

Kada China Resources Medical Holdings Company moka dividendus?

China Resources Medical Holdings Company moka dividendus kas ketvirtį. Jie išmokami liepa, liepa, liepa, spalis mėnesiais.

Kokia saugi yra China Resources Medical Holdings Company dividendų išmokėjimas?

China Resources Medical Holdings Company per paskutiniuosius 13 metus kiekvienais metais mokėjo dividendus.

Kokia yra China Resources Medical Holdings Company dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,04 CNY. Tai atitinka 1,17 % dividendų grąžos procentą.

Kokiame sektoriuje yra China Resources Medical Holdings Company?

China Resources Medical Holdings Company priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von China Resources Medical Holdings Company kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį China Resources Medical Holdings Company dividendą nuo 2024-10-25, kurio dydis yra 0,055 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-09-09.

Kada China Resources Medical Holdings Company paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-10-25.

Kokia buvo China Resources Medical Holdings Company dividendų suma 2023 metais?

2023 metais China Resources Medical Holdings Company išmokėjo 0,12 CNY dividendų.

Kokia valiuta China Resources Medical Holdings Company moka dividendus?

China Resources Medical Holdings Company dividendai yra mokami CNY.

Birža	China Resources Medical Holdings Company Akcijų kodas
FRANKFURTAS	1PH.F
HKSE	1515.HK

China Resources Medical Holdings Company Akcijų kodas	China Resources Medical Holdings Company FIGI
1515:HK	BBG005L6RV12
1PH:GR	BBG005NJVS87
1PH:GF	BBG005NJVS96
1PH:GS	BBG005NJVSD1
1PH:TH	BBG00C3MM319
1515EUR:EO	BBG00CTTK3X3
1515EUR:XH	BBG00CTTK407
1515EUR:XF	BBG00CTTK425
1515EUR:XE	BBG00CTTK443
1515EUR:XJ	BBG00CTTK452
1515EUR:XL	BBG00CTTK461
1515EUR:XG	BBG00CTTK470
1515EUR:XO	BBG00CTTK489
1515EUR:XS	BBG00CTTK4D3
1515EUR:XA	BBG00CTTK4F1
1515EUR:E1	BBG00CTTK4G0
1515EUR:XT	BBG00CTTK4H9
1515EUR:XW	BBG00CTTK4J7
1515EUR:XU	BBG00CTTK4K5
1515EUR:XV	BBG00CTTK4L4
1515EUR:EU	BBG00CTTK4N2
1515:H2	BBG00F135N11
1515:H1	BBG00HMKF2K0
1515EUR:XX	BBG00JN8HDS8
1515N:PO	BBG00JRFTWR4
1515N:L3	BBG00JRG0WL9
1515N:B3	BBG00JRG46R6
1515HKD:X2	BBG00JRGFZW4
1515HKD:XB	BBG00JRGFZX3
1515HKD:XH	BBG00JRGFZZ1
1515HKD:XF	BBG00JRGG014
1515HKD:XE	BBG00JRGG032
1515HKD:XJ	BBG00JRGG041
1515HKD:XL	BBG00JRGG050
1515HKD:XG	BBG00JRGG069
1515HKD:XO	BBG00JRGG078
1515HKD:XS	BBG00JRGG0C2
1515HKD:XA	BBG00JRGG0D1
1515HKD:E1	BBG00JRGG0F9
1515HKD:XT	BBG00JRGG0G8
1515HKD:XW	BBG00JRGG0H7
1515HKD:XU	BBG00JRGG0J5
1515HKD:XV	BBG00JRGG0K3
1515HKD:XM	BBG00JRGG0L2
1515HKD:XQ	BBG00JRGG0N0
1515HKD:XX	BBG00JRGG0P8
1515HKD:XZ	BBG00JRGG0Q7
1515HKD:EU	BBG00JRGG0S5
1515N:L1	BBG00Y7B11S9
1PH:LA	BBG018H99V14
1PH:LU	BBG018J2YVV6

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodas1515.HK

ISINKYG2133W1087

VVPA2DHMW

China Resources Medical Holdings Company akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

China Resources Medical Holdings Company Akcijų istorija

China Resources Medical Holdings Company akcijų apyvarta, EBIT, pelnas KYG2133W1087 · A2DHMW

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

China Resources Medical Holdings Company Pajamų, pelno ir EBIT istorija.

China Resources Medical Holdings Company Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

China Resources Medical Holdings Company Akcijos Maržos KYG2133W1087 · A2DHMW

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

China Resources Medical Holdings Company Maržų istorija

China Resources Medical Holdings Company akcijos apyvarta, EBIT, pelnas vienai akcijai KYG2133W1087 · A2DHMW

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

China Resources Medical Holdings Company Pardavimų, pelno ir EBIT istorija vienai akcijai

China Resources Medical Holdings Company akcija ir akcijų analizė

China Resources Medical Holdings Company vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

China Resources Medical Holdings Company įvertinimas pagal istorinį P/E, EBIT ir P/S

China Resources Medical Holdings Company akcijų skaičius KYG2133W1087 · A2DHMW

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

China Resources Medical Holdings Company akcijos dividendas KYG2133W1087 · A2DHMW

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

China Resources Medical Holdings Company Dividendų istorija

China Resources Medical Holdings Company akcijų išmokėjimo koeficientas KYG2133W1087 · A2DHMW

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

China Resources Medical Holdings Company Dividendų išmokėjimo istorija

China Resources Medical Holdings Company Pelno prognozės

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
1515.HK

ISIN
KYG2133W1087

VVP
A2DHMW